Clearmind Medicine (Clearmind Medicine) Days Inventory : 0.00 (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Clearmind Medicine's Average Total Inventories for the three months ended in Jan. 2024 was $0.00 Mil. Clearmind Medicine's Cost of Goods Sold for the three months ended in Jan. 2024 was $0.00 Mil.

The historical rank and industry rank for Clearmind Medicine's Days Inventory or its related term are showing as below:

CMND's Days Inventory is not ranked ^*
in the Biotechnology industry.
Industry Median: 194.42
* Ranked among companies with meaningful Days Inventory only.

Clearmind Medicine's Days Inventory stayed the same from Jan. 2023 (0.00) to Jan. 2024 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Clearmind Medicine Days Inventory Historical Data

The historical data trend for Clearmind Medicine's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine Days Inventory Chart

Clearmind Medicine Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Days Inventory

Get a 7-Day Free Trial

Clearmind Medicine Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Days Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Clearmind Medicine's Days Inventory

For the Biotechnology subindustry, Clearmind Medicine's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clearmind Medicine's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearmind Medicine's Days Inventory distribution charts can be found below:

* The bar in red indicates where Clearmind Medicine's Days Inventory falls into.

Clearmind Medicine Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Clearmind Medicine's Days Inventory for the fiscal year that ended in Oct. 2023 is calculated as

	Days Inventory (A: Oct. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Oct. 2022 )	+	Total Inventories (A: Oct. 2023 ))	/	count )	/	Cost of Goods Sold (A: Oct. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Clearmind Medicine's Days Inventory for the quarter that ended in Jan. 2024 is calculated as:

	Days Inventory (Q: Jan. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Oct. 2023 )	+	Total Inventories (Q: Jan. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jan. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Clearmind Medicine (NAS:CMND) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Clearmind Medicine's Inventory Turnover for the three months ended in Jan. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Clearmind Medicine's Inventory to Revenue for the three months ended in Jan. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Clearmind Medicine Days Inventory Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearmind Medicine (Clearmind Medicine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (NAS:CMND) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

CWY0:Germany CWY0:Germany CMND:Canada

Address

101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5

Website

https://www.clearmindmedicine.com

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.